Vantage Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$8K Hold
230
﹤0.01% 564
2018
Q2
$7K Buy
230
+30
+15% +$913 ﹤0.01% 590
2018
Q1
$5K Buy
+200
New +$5K ﹤0.01% 657